DE69836023D1 - Neue verbindungen - Google Patents

Neue verbindungen

Info

Publication number
DE69836023D1
DE69836023D1 DE69836023T DE69836023T DE69836023D1 DE 69836023 D1 DE69836023 D1 DE 69836023D1 DE 69836023 T DE69836023 T DE 69836023T DE 69836023 T DE69836023 T DE 69836023T DE 69836023 D1 DE69836023 D1 DE 69836023D1
Authority
DE
Germany
Prior art keywords
new connections
connections
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69836023T
Other languages
English (en)
Other versions
DE69836023T2 (de
Inventor
Joanne Broadhead
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20407718&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69836023(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of DE69836023D1 publication Critical patent/DE69836023D1/de
Application granted granted Critical
Publication of DE69836023T2 publication Critical patent/DE69836023T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
DE69836023T 1997-07-11 1998-06-29 Neue Formulierung Expired - Lifetime DE69836023T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9702680A SE9702680D0 (sv) 1997-07-11 1997-07-11 New formulation
SE9702680 1997-07-11
PCT/SE1998/001287 WO1999002542A1 (en) 1997-07-11 1998-06-29 New formulation

Publications (2)

Publication Number Publication Date
DE69836023D1 true DE69836023D1 (de) 2006-11-09
DE69836023T2 DE69836023T2 (de) 2007-04-12

Family

ID=20407718

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69836023T Expired - Lifetime DE69836023T2 (de) 1997-07-11 1998-06-29 Neue Formulierung

Country Status (36)

Country Link
US (1) US6130208A (de)
EP (1) EP1000079B1 (de)
JP (1) JP4950380B2 (de)
KR (1) KR100786654B1 (de)
CN (2) CN1864696A (de)
AR (1) AR013157A1 (de)
AT (1) ATE340801T1 (de)
AU (1) AU8362598A (de)
BR (1) BR9810703A (de)
CA (1) CA2295628C (de)
CY (1) CY1105805T1 (de)
CZ (1) CZ298110B6 (de)
DE (1) DE69836023T2 (de)
DK (1) DK1000079T3 (de)
EE (1) EE04119B1 (de)
ES (1) ES2273425T3 (de)
HK (1) HK1026429A1 (de)
HU (1) HU226489B1 (de)
ID (1) ID24716A (de)
IL (2) IL133868A0 (de)
IS (1) IS2439B (de)
MY (1) MY116421A (de)
NO (1) NO329918B1 (de)
NZ (1) NZ502073A (de)
PL (1) PL192768B1 (de)
PT (1) PT1000079E (de)
RU (1) RU2216330C2 (de)
SA (1) SA98190328B1 (de)
SE (1) SE9702680D0 (de)
SI (1) SI1000079T1 (de)
SK (1) SK285766B6 (de)
TR (1) TR200000006T2 (de)
TW (1) TW585764B (de)
UA (1) UA65576C2 (de)
WO (1) WO1999002542A1 (de)
ZA (1) ZA985669B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006038647A1 (ja) * 2004-10-05 2006-04-13 Asahi Kasei Pharma Corporation 補酵素の安定化方法およびその組成物
US8759316B2 (en) 2008-05-13 2014-06-24 The Medicines Company Maintenance of platelet inhibition during antiplatelet therapy
US20130303477A1 (en) 2008-05-13 2013-11-14 The Medicines Company Maintenance of Platelet Inhibition During Antiplatelet Therapy
US20120141468A1 (en) * 2008-05-13 2012-06-07 Lisa Ruderman Chen Maintenance of platelet inhibition during antiplatelet therapy
US9427448B2 (en) 2009-11-11 2016-08-30 The Medicines Company Methods of treating, reducing the incidence of, and/or preventing ischemic events
WO2009140092A1 (en) 2008-05-13 2009-11-19 The Medicines Company Maintenance of platelet inhibition during antiplatelet therapy
EP2471792B1 (de) 2009-08-28 2014-04-09 Daiichi Sankyo Company, Limited 3-(biaryloxy-)propionsäurederivat
EA028885B1 (ru) 2009-11-11 2018-01-31 Чиези Фармачеутичи С.П.А. Способы лечения или предотвращения тромбоза стента и инфаркта миокарда (варианты)
US10376532B2 (en) 2009-11-11 2019-08-13 Chiesi Farmaceutici, S.P.A. Methods of treating, reducing the incidence of, and/or preventing ischemic events
US9622967B2 (en) * 2010-12-10 2017-04-18 Sigmapharm Laboratories, Llc Highly stable compositions of orally active nucleotide analogues or orally active nucleotide analogue prodrugs
JP5947316B2 (ja) 2011-02-09 2016-07-06 ザ メディシンズ カンパニー 肺高血圧症を処置するための方法
ES2657019T3 (es) 2011-08-17 2018-03-01 Samuel Shiber Catéter giratorio adaptativo para abrir vasos corporales obstruidos
EP2964233B1 (de) 2013-03-09 2021-12-15 Chiesi Farmaceutici S.p.A. Verfahren zur behandlung, verringerung der inzidenz und/oder prävention von ischämischen ereignissen
CN103772461A (zh) * 2014-01-06 2014-05-07 南京正科制药有限公司 一种坎格雷洛晶型ⅰ
BR112017014996A2 (pt) 2015-01-14 2018-03-20 Chiesi Farm Spa formulações farmacêuticas e recipientes selados
BR112019022676A2 (pt) 2017-06-23 2020-05-19 Chiesi Farm Spa método de prevenção de trombose de derivação da artéria sistêmica-para-pulmonar
TW202016088A (zh) 2018-06-19 2020-05-01 德商Ｕｃｂ製藥有限公司 吡啶基及吡基-（氮）吲哚磺醯胺

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5637967B2 (de) * 1973-05-17 1981-09-03
JPS5874966A (ja) * 1981-10-28 1983-05-06 Mikuni Jukogyo Kk 高圧往復動機の軸封装置
JPS5874696A (ja) * 1981-10-30 1983-05-06 株式会社　ヤトロン アデノシン三リン酸の安定化方法
AU659645B2 (en) * 1991-06-26 1995-05-25 Inhale Therapeutic Systems Storage of materials
ES2129048T3 (es) * 1991-12-09 1999-06-01 Asahi Chemical Ind Composicion estabilizada de hormona paratiroide.
ES2108425T3 (es) * 1993-02-10 1997-12-16 Astra Pharma Prod Analogos de atp sustituidos con n-alquilo-2.
RU2135176C1 (ru) * 1993-12-14 1999-08-27 Эли Лилли Энд Компани Водорастворенный комплекс включения соединений бензотиофена с водорастворимым циклодекстрином, способ его получения и фармацевтическая композиция
DE4405426A1 (de) * 1994-02-21 1995-08-24 Boehringer Mannheim Gmbh Pharmazeutisches Präparat enthaltend Plasminogenaktivator (t-PA) oder dessen Derivate
EP1491217A1 (de) * 1995-06-07 2004-12-29 The Regents Of The University Of California Stabilisierung von Polynukleotidkomplexen
FR2740686B1 (fr) * 1995-11-03 1998-01-16 Sanofi Sa Formulation pharmaceutique lyophilisee stable
SE9604795D0 (sv) * 1996-12-20 1996-12-20 Astra Pharma Prod New pharmaceutical formulation

Also Published As

Publication number Publication date
CA2295628A1 (en) 1999-01-21
NO329918B1 (no) 2011-01-24
SE9702680D0 (sv) 1997-07-11
IS5331A (is) 1999-12-30
SA98190328B1 (ar) 2006-08-15
US6130208A (en) 2000-10-10
HUP0002622A2 (hu) 2001-05-28
WO1999002542A1 (en) 1999-01-21
AU8362598A (en) 1999-02-08
UA65576C2 (uk) 2004-04-15
IL133868A0 (en) 2001-04-30
NO20000123L (no) 2000-03-03
HK1026429A1 (en) 2000-12-15
IL133868A (en) 2010-05-17
PL337970A1 (en) 2000-09-11
EP1000079B1 (de) 2006-09-27
IS2439B (is) 2008-11-15
NO20000123D0 (no) 2000-01-10
BR9810703A (pt) 2000-08-08
CY1105805T1 (el) 2011-02-02
SK285766B6 (sk) 2007-07-06
DE69836023T2 (de) 2007-04-12
HU226489B1 (en) 2009-03-02
PT1000079E (pt) 2006-12-29
NZ502073A (en) 2001-09-28
CN1864696A (zh) 2006-11-22
CN1263533A (zh) 2000-08-16
KR100786654B1 (ko) 2007-12-21
MY116421A (en) 2004-01-31
ZA985669B (en) 1999-01-11
KR20010021647A (ko) 2001-03-15
CZ200083A3 (cs) 2000-06-14
RU2216330C2 (ru) 2003-11-20
EP1000079A1 (de) 2000-05-17
EE200000022A (et) 2000-10-16
PL192768B1 (pl) 2006-12-29
SK183699A3 (en) 2000-07-11
SI1000079T1 (sl) 2007-08-31
EE04119B1 (et) 2003-08-15
JP4950380B2 (ja) 2012-06-13
CA2295628C (en) 2008-07-29
ID24716A (id) 2000-08-03
CZ298110B6 (cs) 2007-06-27
ES2273425T3 (es) 2007-05-01
JP2001509512A (ja) 2001-07-24
DK1000079T3 (da) 2006-11-20
AR013157A1 (es) 2000-12-13
ATE340801T1 (de) 2006-10-15
HUP0002622A3 (en) 2002-04-29
TR200000006T2 (tr) 2000-07-21
TW585764B (en) 2004-05-01

Similar Documents

Publication Publication Date Title
DE69838791D1 (de) Neue exendinagonist verbindungen
DE69805769T2 (de) Entzündungshemmende verbindungen
DE69528825T2 (de) Dendrime verbindungen
ATE225792T1 (de) Neue spiroazabizyklische heterozyklische verbindungen
DE69804498T2 (de) Neue wasserlösliche photochromische verbindungen
ATE355264T1 (de) Neue aryloxy-alkyl-dialkylamine
DE69635700D1 (de) Neue endoglukanase
ATE261964T1 (de) Neue antiarrhytmische bispidin-verbindungen
DE69822740D1 (de) Verbinder
DE69818266D1 (de) Neue substituierte imidazolverbindungen
DE59808013D1 (de) Ventileinrichtung
DE69819057D1 (de) Verbinder
DE69807397T2 (de) Triazinylaminostilben Verbindungen
DE69834906D1 (de) Verbinder
DE69716904T2 (de) Neue verbindungen
DE69836023D1 (de) Neue verbindungen
DE69824201D1 (de) Neue 9a-azalide
DE69829560D1 (de) Verbinder
NO973273D0 (no) Sammenkoblingselement
DE69807105T2 (de) Photochromische verbindungen
DE69716094T2 (de) Bromotiacumicin verbindungen
DE69823611D1 (de) Verbinder
DE69838828D1 (de) Verbinder
DE29718724U1 (de) Bauelemente-Verbindung
DE69802923T2 (de) neue tetrahydroiosoquinolin thiophenecarboximidamiden

Legal Events

Date Code Title Description
8364 No opposition during term of opposition